Cargando…
PPARβ/δ-dependent MSC metabolism determines their immunoregulatory properties
Mesenchymal stem cell (MSC)-based therapy is being increasingly considered a powerful opportunity for several disorders based on MSC immunoregulatory properties. Nonetheless, MSC are versatile and plastic cells that require an efficient control of their features and functions for their optimal use i...
Autores principales: | Contreras-Lopez, R. A., Elizondo-Vega, R., Torres, M. J., Vega-Letter, A. M., Luque-Campos, N., Paredes-Martinez, M. J., Pradenas, C., Tejedor, G., Oyarce, K., Salgado, M., Jorgensen, C., Khoury, M., Kronke, G., Garcia-Robles, M. A., Altamirano, C., Luz-Crawford, P., Djouad, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351754/ https://www.ncbi.nlm.nih.gov/pubmed/32651456 http://dx.doi.org/10.1038/s41598-020-68347-x |
Ejemplares similares
-
PPARβ/δ-Interfering Peptide Enhanced Mesenchymal Stromal Cell Immunoregulatory Properties
por: Tejedor, Gautier, et al.
Publicado: (2022) -
The ATP synthase inhibition induces an AMPK-dependent glycolytic switch of mesenchymal stem cells that enhances their immunotherapeutic potential
por: Contreras-Lopez, Rafael, et al.
Publicado: (2021) -
Time-dependent LPS exposure commands MSC immunoplasticity through TLR4 activation leading to opposite therapeutic outcome in EAE
por: Kurte, Mónica, et al.
Publicado: (2020) -
The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming
por: Luque-Campos, Noymar, et al.
Publicado: (2021) -
Mechanisms behind the Immunoregulatory Dialogue between Mesenchymal Stem Cells and Th17 Cells
por: Terraza-Aguirre, Claudia, et al.
Publicado: (2020)